Mark Lappe's Net Worth
$85.6 Million
Who is Mark Lappe?
Mark Lappe has an estimated net worth of $85.6 Million. This is based on reported shares across multiple companies, which include REPROS THERAPEUTICS INC., AEOLUS PHARMACEUTICALS, INC., and Inhibrx, Inc..
SEC CIK
Mark Lappe's CIK is 0001366074
Past Insider Trading and Trends
2008 was Mark Lappe's most active year for acquiring shares with 29 total transactions. Mark Lappe's most active month to acquire stocks was the month of September. 2022 was Mark Lappe's most active year for disposing of shares, totalling 13 transactions. Mark Lappe's most active month to dispose stocks was the month of February. 2008 saw Mark Lappe paying a total of $28,562,851.34 for 4,317,360 shares, this is the most they've acquired in one year. In 2011 Mark Lappe cashed out on 9,075,287 shares for a total of $4,077,011.64, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Inhibrx, Inc. (INBX) Snapshot price: $37.91
Chief Executive Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -0.00% | -60.00 |
$25.02 | -$1,501.25 | 2.49M |
Scheduled
|
Feb 28
| ||
Form 4
| -1.03% | -26.00K |
$25.42 | -$660,841.96 | 2.49M |
Scheduled
|
Jan 23 - Jan 24
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 3
| |||
Form 4
| -1.02% | -26.00K |
$25.56 | -$664,443.36 | 2.51M |
Scheduled
|
Dec 19
| ||
Form 4
| -1.01% | -26.00K |
$27.88 | -$724,909.78 | 2.54M |
Scheduled
|
Nov 17
| ||
Form 4
| -1.00% | -26.00K |
$29.59 | -$769,443.22 | 2.56M |
Scheduled
|
Oct 17
| ||
Form 4
|
—
|
0
|
—
|
—
| 3.09M |
Dec 28 - Jan 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
REPROS THERAPEUTICS INC. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -5.79% | -156.80K |
$0.67 | -$105,702.41 | 2.55M |
Dec 17 - Dec 21
| |||
Form 4
| -12.47% | -386.10K |
$0.68 | -$264,235.10 | 2.71M |
Dec 11 - Dec 15
| |||
Form 4
| -14.88% | -541.00K |
$0.70 | -$380,553.40 | 3.1M |
Nov 30 - Dec 2
| |||
Form 4
| -15.28% | -656.00K |
$0.72 | -$471,400.40 | 3.64M |
Nov 19 - Nov 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 20
| |||
Form 4
| +0.26% | 11.3K |
$7.76 | $87,688.00 | 4.29M |
Oct 31
| |||
Form 4
| +0.26% | 11.3K |
$7.76 | $87,688.00 | 4.29M |
Oct 31
| |||
Form 4
| +0.81% | 34.29K |
$6.94 | $238,026.04 | 4.28M |
Oct 28 - Oct 29
| |||
Form 4
| +0.81% | 34.29K |
$6.94 | $238,026.04 | 4.28M |
Oct 28 - Oct 29
| |||
Form 4
| +1.48% | 62.13K |
$6.72 | $417,644.13 | 4.25M |
Oct 23 - Oct 27
| |||
Form 4
| +1.48% | 62.13K |
$6.72 | $417,644.13 | 4.25M |
Oct 23 - Oct 27
| |||
Form 4
| +0.72% | 30K |
$6.42 | $192,600.00 | 4.18M |
Oct 17
| |||
Form 4
| +0.72% | 30K |
$6.42 | $192,600.00 | 4.18M |
Oct 17
| |||
Form 4
| +0.73% | 30.3K |
$6.52 | $197,619.00 | 4.15M |
Oct 10 - Oct 13
| |||
Form 4
| +0.73% | 30.3K |
$6.52 | $197,619.00 | 4.15M |
Oct 10 - Oct 13
| |||
Form 4
| +81.04% | 1.85M |
$6.50 | $12,000,001.00 | 4.12M |
Oct 2
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Sep 29
| |||
Form 4
| +81.04% | 1.85M |
$6.50 | $12,000,001.00 | 4.12M |
Oct 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
| -11.71% | -302.06K |
$9.21 | -$2,783,355.78 | 2.28M |
Mar 14 - Mar 27
| |||
Form 4
| +1.98% | 50K |
$8.50 | $425,000.00 | 2.58M |
Mar 12
| |||
Form 4
| +1.49% | 74.5K |
$8.55 | $636,135.00 | 5.06M |
Mar 7 - Mar 10
| |||
Form 4
| +2.08% | 50K |
$8.30 | $415,100.00 | 2.46M |
Feb 28 - Feb 29
| |||
Form 4
| +0.73% | 34.5K |
$9.02 | $311,460.00 | 4.79M |
Jan 4 - Jan 7
| |||
Form 4
| +5.52% | 124.1K |
$9.37 | $1,162,563.00 | 2.37M |
Dec 28 - Dec 31
| |||
Form 4
| +4.66% | 100K |
$9.45 | $944,600.00 | 2.25M |
Dec 20 - Dec 21
| |||
Form 4
| +24.64% | 85.6K |
$9.82 | $840,199.00 | 433.04K |
Dec 18 - Dec 19
| |||
Form 4
| +8.42% | 160.1K |
$9.51 | $1,522,470.00 | 2.06M |
Dec 13 - Dec 14
| |||
Form 4
| +5.51% | 99.3K |
$8.05 | $799,074.00 | 1.9M |
Dec 5 - Dec 6
| |||
Form 4
| +7.23% | 121.5K |
$8.06 | $979,490.00 | 1.8M |
Dec 3 - Dec 4
| |||
Form 4
| +31.61% | 217K |
$12.46 | $2,699,023.90 | 903.6K |
Oct 17 - Oct 25
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
AEOLUS PHARMACEUTICALS, INC. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -47.86% | -3.99M |
$0.62 | -$2,464,479.64 | 4.35M |
Mar 15 - Mar 16
| |||
Form 4
| -0.77% | -64.60K |
$0.97 | -$62,522.00 | 8.34M |
Feb 15 - Feb 16
| |||
Form 4
| -14.22% | -1.39M |
—
|
—
| 8.41M |
Jan 6 - Feb 8
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Inhibrx Biosciences, Inc. No price found
Chief Executive Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||